COFCO Biotechnology Co

COFCO Biotechnology Co Debt

The Debt of COFCO Biotechnology Co (000930.SZ) as of Nov 3, 2026 is 367.80 M CNY. In the previous year, Debt was 4.34 B CNY — a change of -91.53% (lower).

Debt

367.80 MCNY

YoY

-91.53%

Last updated:

In 2025, COFCO Biotechnology Co's total debt was 367.80 M CNY, a -91.53% change from the 4.34 B CNY total debt recorded in the previous year.

The COFCO Biotechnology Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
5.80 B CNY
Jan 1, 2019
3.01 B CNY
Jan 1, 2020
6.83 B CNY
Jan 1, 2021
3.40 B CNY
Jan 1, 2022
3.23 B CNY
Jan 1, 2023
3.76 B CNY
Jan 1, 2024
4.34 B CNY
Jan 1, 2025
367.80 M CNY
The COFCO Biotechnology Co Debt history
YEARDebtYoY
367.80 MCNY-91.53%
4.34 BCNY+15.44%
3.76 BCNY+16.59%
3.23 BCNY-4.99%
3.40 BCNY-50.29%
6.83 BCNY+127.20%
3.01 BCNY-48.21%
5.80 BCNY+107.54%
2.80 BCNY+11.65%
2.50 BCNY-17.21%
3.03 BCNY+7.80%
2.81 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

COFCO Biotechnology Co Stock analysis

What does COFCO Biotechnology Co do? COFCO Biotechnology Co., Ltd. generates revenue through the production and sale of fuel ethanol, edible alcohol, starch, starch sugar, citric acid, and monosodium glutamate along with their by-products. The company's main product lines include fuel ethyl alcohol products, citric acid products and their salts, amino acid products, edible oil, and L-lactic acid products, which are distributed domestically and internationally. Domestic markets and overseas markets are the primary segments purchasing these products, with the company focusing on both industrial and consumer applications of its chemical and food-grade outputs. The firm's product portfolio spans multiple sectors including biofuels, food additives, and industrial chemicals, serving various industries through its diverse range of offerings. The company's revenue streams are derived from the sale of its core products such as fuel ethanol, citric acid, and amino acid derivatives, which are sold to industrial clients and food manufacturers. By-products from these production processes are also sold, enhancing overall profitability. The domestic market remains a key sales channel, while international distribution supports growth in overseas regions, particularly where demand for bio-based products is rising. COFCO Biotechnology leverages its production capabilities to serve both local and global customers with consistent product quality and supply. COFCO Biotechnology's business model centers on manufacturing and distributing a wide array of chemical and food-related products. Its primary customers are industrial buyers seeking raw materials for biofuel production, food processing, and chemical manufacturing. The company's product mix includes high-demand items like fuel ethanol for energy applications and citric acid for food and pharmaceutical uses. By maintaining a strong presence in both domestic and international markets, the company ensures steady revenue from multiple product lines and geographic segments. COFCO Biotechnology Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding COFCO Biotechnology Co's Debt Structure

COFCO Biotechnology Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing COFCO Biotechnology Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to COFCO Biotechnology Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in COFCO Biotechnology Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about COFCO Biotechnology Co stock

Debt of COFCO Biotechnology Co is 367.80 M CNY in 2025.

Debt of COFCO Biotechnology Co changed from 4.34 B CNY to 367.80 M CNY, representing a -91.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt COFCO Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Debt's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's COFCO Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — COFCO Biotechnology Co

All Key Metrics — COFCO Biotechnology Co